MCID: CHR070
MIFTS: 39

Chronic Inflammatory Demyelinating Polyradiculoneuropathy malady

Neuronal diseases category

Aliases & Classifications for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

About this section
Sources:
10Disease Ontology, 12DISEASES, 47Novoseek, 65UMLS, 36MeSH, 42NCIt, 59SNOMED-CT
See all sources

Aliases & Descriptions for Chronic Inflammatory Demyelinating Polyradiculoneuropathy:

Name: Chronic Inflammatory Demyelinating Polyradiculoneuropathy 10 12
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 65 36
 
Polyradiculoneuropathy Chronic Inflammatory Demyelinating 47


Classifications:



External Ids:

Disease Ontology10 DOID:5213
NCIt42 C84636
SNOMED-CT59 128209004
MeSH36 D020277

Summaries for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

About this section
MalaCards based summary: Chronic Inflammatory Demyelinating Polyradiculoneuropathy, also known as polyradiculoneuropathy, chronic inflammatory demyelinating, is related to polyradiculoneuropathy and neuropathy, inflammatory demyelinating. An important gene associated with Chronic Inflammatory Demyelinating Polyradiculoneuropathy is MPZ (Myelin Protein Zero), and among its related pathways are Cytokines and Inflammatory Response and Neural Crest Differentiation. The drug immunoglobulins, intravenous has been mentioned in the context of this disorder. Affiliated tissues include spinal cord, t cells and brain, and related mouse phenotypes are muscle and no phenotypic analysis.

Related Diseases for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

About this section

Diseases related to Chronic Inflammatory Demyelinating Polyradiculoneuropathy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 144)
idRelated DiseaseScoreTop Affiliating Genes
1polyradiculoneuropathy32.3MBP, MPZ, PMP22
2neuropathy, inflammatory demyelinating30.9MPZ, PMP22
3demyelinating polyneuropathy30.6IFNB1, IFNG, IL17A, MBP
4cauda equina syndrome30.6IFNG, STAT1
5neuropathy10.8
6chronic inflammatory demyelinating polyneuropathy10.8
7polyneuropathy10.8
8critical illness polyneuropathy10.7
9autoimmune disease of the nervous system10.7
10chronic polyneuropathy10.7
11demyelinating disease10.7
12hypersensitivity reaction type ii disease10.7
13neuromuscular disease10.7
14peripheral nervous system disease10.7
15peripheral neuropathy10.7
16neurologic diseases10.7
17autoimmune disease 110.6
18systemic lupus erythematosus10.6
19multifocal motor neuropathy10.6
20lupus erythematosus10.6
21autoimmune disease 210.6
22cervicitis10.6
23autoimmune disease 310.5
24glomerulonephritis10.5
25myasthenia gravis10.5
26membranous glomerulonephritis10.5
27autoimmune disease of blood10.5
28influenza10.5
29neuritis10.5
30ophthalmoplegia10.5
31ptosis10.5
32withdrawal disorder10.5
33autonomic dysfunction10.5
34dawson disease10.5
35hepatocellular carcinoma10.3
36autoimmune disease 410.3
37autoimmune disease 610.3
38crohn's disease10.3
39hematopoietic stem cell transplantation10.3
40gamma chain deficiency10.3
41autoimmune disease of central nervous system10.3
42aseptic meningitis10.3
43newcastle disease10.3
44lateral sclerosis10.3
45radiculopathy10.3
46neurofibromatosis10.3
47evans' syndrome10.3
48adjustment disorder10.3
49arthropathy10.3
50guillain-barre syndrome10.3

Graphical network of the top 20 diseases related to Chronic Inflammatory Demyelinating Polyradiculoneuropathy:



Diseases related to chronic inflammatory demyelinating polyradiculoneuropathy

Symptoms for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

About this section

Drugs & Therapeutics for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

About this section

Drugs for Chronic Inflammatory Demyelinating Polyradiculoneuropathy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 21)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
alemtuzumabapproved, investigationalPhase 4293216503-57-0
Synonyms:
Campath
 
Lemtrada
Mabcampath
alemtuzumab
2Rho(D) Immune GlobulinPhase 4, Phase 3, Phase 2198
3Immunoglobulins, IntravenousPhase 4, Phase 3, Phase 2203
4
PrednisoneapprovedPhase 3120853-03-25865
Synonyms:
(1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione
(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione
(8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione
.delta. E
.delta.(sup1)-Cortisone
.delta.-Cortelan
.delta.-Cortisone
.delta.-Cortone
.delta.-E
.delta.1-Cortisone
.delta.1-Dehydrocortisone
.delta.sone
1,2-Dehydrocortisone
1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione
1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione
1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione
1-Cortisone
1-Dehydrocortisone
17,21-Dihydroxypregna-1,4-diene-3,11,20-trione
17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione
53-03-2
68-59-7
81552_FLUKA
AC-11112
AC1L1LB2
AC1Q29EZ
ACon0_000082
ACon1_000297
AI3-52939
Adasone
Ancortone
Apo-Prednisone
Apo-prednisone
BPBio1_000323
BRD-K85883481-001-04-2
BSPBio_000293
Betapar
Bicortone
Bio-0649
C07370
C21H26O5
CCRIS 2646
CHEBI:8382
CHEMBL635
CID5865
CPD001227202
Cartancyl
Colisone
Cortan
Cortancyl
Cortidelt
Cotone
DB00635
Dacorten
Dacortin
Decortancyl
Decortin
Decortisyl
Dehydrocortisone
Dekortin
Delcortin
Dellacort
Dellacort A
Delta Cortelan
Delta E
Delta E.
Delta-Cortelan
Delta-Dome
Delta-cortelan
Delta-cortisone
Delta-cortone
Delta-dome
Deltacortene
Deltacortisone
Deltacortone
Deltasone
Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone
Deltison
Deltisona
Deltisone
Deltra
Di-Adreson
Diadreson
EINECS 200-160-3
Econosone
Encorton
Encortone
Enkortolon
Enkorton
Fernisone
Fiasone
HMS1568O15
HMS2090J13
HSDB 3168
Hostacortin
In-Sone
Incocortyl
Juvason
 
Kortancyl
LMST02030180
LS-1325
Liquid Pred
Lisacort
Lodotra
MEGxm0_000443
MLS001061265
MLS001304073
MLS001335907
MLS001335908
MLS002154191
MLS002207083
Me-Korti
Metacortandracin
Meticorten
Meticorten (Veterinary)
Metrevet (Veterinary)
MolPort-001-740-041
NCGC00090766-01
NCGC00090766-02
NCGC00090766-03
NCI-C04897
NCI60_000008
NSC 10023
NSC10023
Nisona
Nizon
Novoprednisone
Nurison
Orasone
Origen Prednisone
P1276
P6254_SIGMA
PRD
Panafcort
Panasol
Paracort
Parmenison
Pehacort
Perrigo Prednisone
Precort
Predeltin
Prednicen-M
Prednicorm
Prednicort
Prednicot
Prednidib
Prednilonga
Prednison
Prednisona
Prednisona [INN-Spanish]
Prednisone
Prednisone Intensol
Prednisone [INN:BAN]
Prednisonum
Prednisonum [INN-Latin]
Prednitone
Prednizon
Prednovister
Presone
Prestwick0_000077
Prestwick1_000077
Prestwick2_000077
Prestwick3_000077
Prestwick_405
Pronison
Pronisone
Rayos
Rectodelt
Retrocortine
S1622_Selleck
SAM002264641
SK-Prednisone
SMR000718760
SMR001227202
SPBio_002214
Servisone
Sone
Sterapred
Supercortil
U 6020
UNII-VB0R961HZT
Ultracorten
Ultracortene
WLN: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ
Winpred
Wojtab
ZINC03875357
Zenadrid
Zenadrid (veterinary)
Zenadrid [veterinary]
delta cortelan
delta(sup 1)-Cortisone
delta(sup 1)-Dehydrocortisone
delta-1-Cortisone
delta-1-Dehydrocortisone
delta-Cortisone
delta-Cortone
5
Mycophenolic acidapprovedPhase 386424280-93-1446541
Synonyms:
(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid
Acide mycophenolique
Acido micofenolico
Acidum mycophenolicum
Melbex
 
Micofenolico acido
Mycophenoic acid
Mycophenolate
Mycophenolic Acid
Mycophenolsaeure
Myfortic
6
Fingolimodapproved, investigationalPhase 382162359-55-9107970
Synonyms:
2-Amino-2-(4-octylphenethyl)propane-1,3-diol
AC1L332W
CHEBI:244940
CHEMBL314854
CID107970
FTY720
Fingolimod
 
Fingolimod Hydrochloride
Fingolimodum
Gilenya
LS-187221
MolPort-003-847-513
UNII-3QN8BYN5QF
nchembio.547-comp4
nchembio804-comp4
7
Mycophenolate mofetilapproved, investigationalPhase 3864128794-94-55281078
Synonyms:
115007-34-6
128794-94-5
140401-05-4
2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate
2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate
4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl -3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E)
AC-1562
AC1NQXZW
AC1Q6O6X
AR-1J6939
BB_NC-2566
C07908
C23H31NO7
CHEMBL1456
CID5281078
CellCept
CellCept, RS 61443, TM-MMF, Mycophenolate mofetil
Cellcept
Cellcept (TN)
D00752
DB00688
HMS2090A03
 
HSDB 7436
I01-0898
I06-1947
LS-172272
LS-75572
ME-MPA
MMF
MMF CellCept(TM)
MolPort-000-883-800
Munoloc
Mycophenolate Mofetil
Mycophenolate mofetil (JAN/USAN)
Mycophenolic acid morpholinoethyl ester
Mycophenylate mofetil
NCGC00159459-02
NCGC00159459-03
NSC724229
R-99
RS 61443
RS-61443
RS-61443-190
S1501_Selleck
TL8000648
TM-MMF
UNII-9242ECW6R0
ZINC21297660
mycophenolate mofetil
8
Glycineapproved, nutraceuticalPhase 310256-40-6750
Synonyms:
(1-13c)glycinato
(15N)Glycine
15527_RIEDEL
15527_SIAL
15743-44-9 (mono-potassium salt)
17829-66-2 (cobalt salt)
18875-39-3
2,2-dialkylglycines
2-Aminoacetate
2-Aminoacetic acid
2311-65-1
25718-94-9
29728-27-6 (monoammonium salt)
32817-15-5 (copper salt)
33226_RIEDEL
33226_SIAL
33242-26-1 (calcium salt)
35947-07-0 (calcium salt (2:1))
410225_SIAL
50046_FLUKA
50046_SIGMA
513-29-1 (sulfate (3:1))
52955-63-2
56-40-6
57678-19-0
6000-43-7 (hydrochloride)
6000-44-8 (mono-hydrochloride salt)
63183-41-5 (hydrochloride hydrogen carbonate)
71295-98-2 (phosphate (1:1))
7490-95-1 (hydrochloride (2:1)
7490-95-1 (hydrochloride (2:1))
7575-55-5
848646-45-7
87867-94-5
AB-131/40217813
AB1002628
AC1L19XW
AC1Q28JW
AC1Q53O0
AI3-04085
AKOS000119626
AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER
AR-1A0345
AR-1A0532
Acide aminoacetique
Acide aminoacetique [INN-French]
Acido aminoacetico
Acido aminoacetico [INN-Spanish]
Acidum aminoaceticum
Acidum aminoaceticum [INN-Latin]
Aciport
Amino-Acetate
Amino-Acetic acid
Aminoacetate
Aminoacetic acid
Aminoazijnzuur
Aminoessigsaeure
Aminoethanoate
Aminoethanoic acid
Amitone
B72BA06C-60E9-4A83-A24A-A2D7F465BB65
BPBio1_001222
Biomol-NT_000195
C00037
CCRIS 5915
CHEBI:15428
CHEBI:15705
CHEBI:16228
CHEMBL773
CID750
CPD-8569
Corilin
D00011
DB00145
EINECS 200-272-2
 
FEMA No. 3287
FT-0083159
G
G0099
G0317
G5417_SIGMA
G5523_SIGMA
G7126_SIGMA
G7403_SIGMA
G8790_SIGMA
G8898_SIGMA
GLY (IUPAC abbrev)
GLYCINE 1.5% IN PLASTIC CONTAINER
GLYCINE, ACS
Glicina
Glicina [INN-Spanish]
Glicoamin
Gly
Glycin
Glycine
Glycine (JP15/USP)
Glycine [INN]
Glycine iron sulphate (1:1)
Glycine, homopolymer (VAN)
Glycine, labeled with carbon-14
Glycine, non-medical
Glycine-UL-14C hydrochloride
Glycinum
Glycinum [INN-Latin]
Glycocoll
Glycolixir
Glycosthene
Glykokoll
Glyzin
Gyn-Hydralin
Gyn-hydralin
H-Gly-OH
H2N-CH2-COOH
HSDB 495
Hampshire glycine
Hgly
InChI=1/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5
KST-1A2919
KST-1A8102
L-Glycine
L-alpha-amino acids
L001246
LS-218
Leimzucker
MolPort-000-871-607
NCGC00024503-01
NCGC00024503-02
NChemBio.2007.13-comp1
NSC 25936
NSC25936
P8791_SIGMA
Padil
Polyglycine II
S04-0135
Sucre de gelatine
Tocris-0219
UNII-TE7660XO1C
W328707_ALDRICH
WLN: Z1VQ
aminoacetic acid
an alpha amino acid ester
bmse000089
gly
glycine
nchem.554-comp2
nchembio.121-comp9
nchembio.145-comp33
nchembio.198-comp12
nchembio.265-comp9
nchembio.266-comp30
polyglycine
9AlbunexPhase 3145
10Immunoglobulin GPhase 3167
11
Folic Acidapproved, nutraceuticalPhase 2285159-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic Acid
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
 
Folsaeure
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
12Thioctic AcidPhase 297
13Vitamin B ComplexPhase 22775
14Interferon beta 1aPhase 2191
15Interferon-betaPhase 2244
16beta-endorphinPhase 289
17Adrenocorticotropic HormonePhase 2121
18Vitamin B9NutraceuticalPhase 22851
19FolateNutraceuticalPhase 22851
20Alpha-lipoic AcidNutraceuticalPhase 297
21Gamma-Globulins22

Interventional clinical trials:

(show all 37)
idNameStatusNCT IDPhase
1Alemtuzumab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIPD)RecruitingNCT01757574Phase 4
2IVIg for Demyelination in Diabetes MellitusRecruitingNCT02372149Phase 4
3Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.CompletedNCT01824251Phase 3
4Study of Efficacy and Safety of Privigen in Subjects With Chronic Inflammatory Demyelinating PolyneuropathyCompletedNCT01184846Phase 3
5Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)CompletedNCT00220740Phase 3
6Randomized Open-label Trial to Compare Efficacy and Tolerance of Corticosteroids and IVIgCompletedNCT01349270Phase 3
7Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating PolyneuropathyCompletedNCT00004772Phase 3
8Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating NeuropathyCompletedNCT00004286Phase 3
9Phase III Randomized, Double-Blind, Placebo-Controlled Study of 3,4-Diaminopyridine for Demyelinating PolyneuropathyCompletedNCT00004939Phase 3
10Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients.RecruitingNCT01625182Phase 3
11Phase III Efficacy, Safety, and Tolerability Study of HYQVIA/HyQvia and GAMMAGARD LIQUID/KIOVIG in CIDPRecruitingNCT02549170Phase 3
12Efficacy and Safety Study of I10E in Treatment of Patients With CIDPRecruitingNCT02293460Phase 3
13Efficacy and Safety Study of I10E in the Maintenance Treatment of Patients With CIDP: Extension of PRISM Study I10E-1302RecruitingNCT02317562Phase 3
14Interest of Mycophenolate for CIDP WeaningRecruitingNCT02494505Phase 3
15Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20)Active, not recruitingNCT01545076Phase 3
16Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Enrolling by invitationNCT02027701Phase 3
17Study to Evaluate Safety and Efficacy of Three Different Dosages of NewGam in Patients With Chronic Inflammatory Demyelinating Poly (Radiculo) NeuropathyNot yet recruitingNCT02638207Phase 3
18Safety and Efficacy Study of Three Different Dosages of NewGam in Patients With CIDPTerminatedNCT01225276Phase 2, Phase 3
19Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)CompletedNCT00099489Phase 2
20Subcutaneous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)CompletedNCT01017159Phase 2
21Lipoic Acid to Treat Chronic Inflammatory Demyelinating PolyneuropathyCompletedNCT00962429Phase 2
22Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)CompletedNCT00001287Phase 2
23Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating PolyneuropathyRecruitingNCT00278629Phase 2
24Stem Cell Transplantation for Stiff Person Syndrome (SPS)RecruitingNCT02282514Phase 1, Phase 2
25Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating NeuropathyNot yet recruitingNCT02574962Phase 2
26High-dose Cyclophosphamide for Moderate to Severe Refractory Chronic Inflammatory Demyelinating PolyneuropathyWithdrawnNCT01236456Phase 2
27Study of CIDP Patients During IVIG TreatmentCompletedNCT00305266
28Immunoglobulin Dosage and Administration Form in CIDP and MMNCompletedNCT02111590
29Prevalence of Decreased Corneal Sensation in Patients With Chronic Inflammatory Demyelinating PolyneuropathyRecruitingNCT01379833
30Biomark Study: Predict Intravenous Immunoglobulin Responders in Chronic Inflammatory Demyelinating PolyradiculoneuropathyRecruitingNCT02629796
31Transcriptome Analysis of the Peripheral Blood in CIDPRecruitingNCT02404298
32Subcutaneous Immunoglobulin for CIDPRecruitingNCT02465359
33IVIg Treatment-Related Fluctuations in CIDP Patients Using Daily Grip Strength MeasurementsRecruitingNCT02414490
34sCD163 & CD19 as Candidate Biomarkers in CIDP and MMNRecruitingNCT02271724
35Magnetic Resonance Diagnostics of Diabetic Peripheral NeuropathyRecruitingNCT01847937
36MRI in Diagnosing and Monitoring CIDPEnrolling by invitationNCT02017769
37Effect of Resistance and Aerobic Exercise in CIDP or MMNEnrolling by invitationNCT02121678

Search NIH Clinical Center for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Inferred drug relations via UMLS65/NDF-RT43:


Cochrane evidence based reviews: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

Genetic Tests for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

About this section

Anatomical Context for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

About this section

MalaCards organs/tissues related to Chronic Inflammatory Demyelinating Polyradiculoneuropathy:

33
Spinal cord, T cells, Brain, Tongue, Nk cells, Thyroid, Kidney

Animal Models for Chronic Inflammatory Demyelinating Polyradiculoneuropathy or affiliated genes

About this section

MGI Mouse Phenotypes related to Chronic Inflammatory Demyelinating Polyradiculoneuropathy:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053698.2ALB, CXCL12, IFNG, PMP22, STAT1
2MP:00030128.0CXCL12, IFNB1, IFNG, IL17A, STAT1
3MP:00028737.6ALB, CXCL12, IFNB1, IFNG, MBP, STAT1
4MP:00053847.3ALB, CXCL12, IFNG, MBP, MPZ, PMP22
5MP:00053766.9ALB, IFNB1, IFNG, IL17A, MBP, MPZ
6MP:00036316.9CXCL12, IFNB1, IFNG, MBP, MPZ, PMP22
7MP:00053976.8CXCL12, IFNB1, IFNG, IL17A, MBP, MPZ
8MP:00107686.8ALB, CXCL12, IFNG, IL17A, MBP, MPZ
9MP:00053876.5CXCL12, IFNB1, IFNG, IL17A, MBP, MPZ

Publications for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

About this section

Articles related to Chronic Inflammatory Demyelinating Polyradiculoneuropathy:

(show top 50)    (show all 279)
idTitleAuthorsYear
1
Long-term Immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy. (25556954)
2015
2
Triple-stimulation technique improves the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy. (25571892)
2015
3
Chronic inflammatory demyelinating polyradiculoneuropathy with cholesterol deposits in a dog. (26450833)
2015
4
Characteristic MRI features of chronic inflammatory demyelinating polyradiculoneuropathy. (25687202)
2015
5
Progressive bilateral ptosis in a patient with midbrain metastasis and chronic inflammatory demyelinating polyradiculoneuropathy. (24594646)
2014
6
Somatosensory evoked potentials in chronic inflammatory demyelinating polyradiculoneuropathy. (24887608)
2014
7
SjAPgren's syndrome associated chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) treated with autologous and subsequently allogeneic haematopoietic SCT (HSCT). (23503533)
2013
8
Chronic inflammatory demyelinating polyradiculoneuropathy in a patient with Crohn's disease. (23291687)
2013
9
Chronic inflammatory demyelinating polyradiculoneuropathy associated intracranial hypertension. (22941356)
2013
10
Chronic inflammatory demyelinating polyradiculoneuropathy in a patient with systemic lupus erythematosus and good outcome with rituximab treatment. (21922339)
2012
11
CD8+ T-cell immunity in chronic inflammatory demyelinating polyradiculoneuropathy. (22238416)
2012
12
Chronic inflammatory demyelinating polyradiculoneuropathy: from bench to bedside. (23117943)
2012
13
Brachial and lumbar plexuses in chronic inflammatory demyelinating polyradiculoneuropathy: MRI assessment including apparent diffusion coefficient. (20405114)
2011
14
Diffusion tensor imaging of peripheral nerve in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a feasibility study. (21318578)
2011
15
Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial. (20133204)
2010
16
Understanding the consequences of chronic inflammatory demyelinating polyradiculoneuropathy from impairments to activity and participation restrictions and reduced quality of life: the ICE study. (21040143)
2010
17
Alemtuzumab: the future of chronic inflammatory demyelinating polyradiculoneuropathy treatment? (20441416)
2010
18
Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. (19160200)
2009
19
Chronic inflammatory demyelinating polyradiculoneuropathy: a role for haematopoietic stem cell transplantation? (18958756)
2008
20
What's new in chronic inflammatory demyelinating polyradiculoneuropathy in 2007-2008? (19192063)
2008
21
Recommendations on diagnostic strategies for chronic inflammatory demyelinating polyradiculoneuropathy. (18716018)
2008
22
Ophthalmoplegia, proptosis, and lid retraction caused by cranial nerve hypertrophy in chronic inflammatory demyelinating polyradiculoneuropathy. (17548992)
2007
23
Rituximab therapy in chronic inflammatory demyelinating polyradiculoneuropathy with anti-SGPG IgM antibody. (16814550)
2006
24
European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. (16643309)
2006
25
Biochemical features of chronic inflammatory demyelinating polyradiculoneuropathy]. (16585917)
2006
26
Chronic inflammatory demyelinating polyradiculoneuropathy: new views and guidelines. (16221282)
2005
27
Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy. (15958128)
2005
28
T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. (16170091)
2005
29
Chronic inflammatory demyelinating polyradiculoneuropathy: MRI study of brain and spinal cord. (15753438)
2005
30
Chronic inflammatory demyelinating polyradiculoneuropathy in patients with liver transplantation. (15372442)
2004
31
Diffuse spinal and intercostal nerve involvement in chronic inflammatory demyelinating polyradiculoneuropathy: MRI findings. (16440223)
2003
32
Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients. (12661048)
2003
33
Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy. (11754181)
2002
34
Cardiovascular autonomic function and sympathetic skin response in chronic inflammatory demyelinating polyradiculoneuropathy. (12402289)
2002
35
Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. (11222785)
2001
36
Chronic inflammatory demyelinating polyradiculoneuropathy with histologically proven optic neuritis. (11484826)
2001
37
Treatment approaches for Guillain-BarrAc syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. (11471764)
2001
38
Ataxic form of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). (10809947)
2000
39
Chronic inflammatory demyelinating polyradiculoneuropathy and severe peripheral oedema: a renal explanation. (10844803)
2000
40
Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England. (10209187)
1999
41
Chronic inflammatory demyelinating polyradiculoneuropathy: superiority of protein A immunoadsorption over plasma exchange treatment. (10178691)
1998
42
A novel trial design to study the effect of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy. (8936360)
1996
43
Immunization and risk of relapse of Guillain-BarrAc syndrome or chronic inflammatory demyelinating polyradiculoneuropathy. (8761286)
1996
44
Long-term treatment of chronic inflammatory demyelinating polyradiculoneuropathy with plasma exchange or intravenous immunoglobulin. (7633875)
1995
45
Chronic inflammatory demyelinating polyradiculoneuropathy. (7921585)
1994
46
Prognosis in long-term immunosuppressive treatment of refractory chronic inflammatory demyelinating polyradiculoneuropathy. (1738011)
1992
47
Chronic inflammatory demyelinating polyradiculoneuropathy associated with Evans' syndrome. (1341469)
1992
48
Chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients with and without an associated monoclonal gammopathy. (1603342)
1992
49
Absence of antimyelin antibodies and serum demyelinating factors in most patients with chronic inflammatory demyelinating polyradiculoneuropathy. (3267485)
1988
50
Chronic nephrotoxicity complicating cyclosporine treatment of chronic inflammatory demyelinating polyradiculoneuropathy. (3796829)
1987

Variations for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

About this section

Expression for genes affiliated with Chronic Inflammatory Demyelinating Polyradiculoneuropathy

About this section
Search GEO for disease gene expression data for Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

Pathways for genes affiliated with Chronic Inflammatory Demyelinating Polyradiculoneuropathy

About this section

Pathways related to Chronic Inflammatory Demyelinating Polyradiculoneuropathy according to GeneCards Suite gene sharing:

(show all 15)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
19.6IFNB1, IFNG
29.3MBP, MPZ, PMP22
39.0CXCL12, IFNG, IL17A
4
Show member pathways
8.8IFNG, IL17A, STAT1
5
Show member pathways
8.8IFNG, IL17A, STAT1
6
Show member pathways
8.8IFNG, IL17A, STAT1
7
Show member pathways
8.8IFNB1, IFNG, STAT1
88.8IFNB1, IFNG, STAT1
98.8IFNB1, IFNG, STAT1
108.8IFNB1, IFNG, STAT1
11
Show member pathways
8.8IFNB1, IFNG, STAT1
128.8IFNB1, IFNG, STAT1
13
Show member pathways
8.3IFNB1, IFNG, IL17A, STAT1
148.2CXCL12, IFNG, IL17A, STAT1
15
Show member pathways
8.2CXCL12, IFNG, IL17A, STAT1

GO Terms for genes affiliated with Chronic Inflammatory Demyelinating Polyradiculoneuropathy

About this section

Cellular components related to Chronic Inflammatory Demyelinating Polyradiculoneuropathy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1external side of plasma membraneGO:00098979.5CXCL12, IFNG, IL17A
2myelin sheathGO:00432099.4ALB, MBP, MPZ
3extracellular spaceGO:00056158.1ALB, CXCL12, IFNB1, IFNG, IL17A
4extracellular regionGO:00055767.8ALB, CXCL12, IFNB1, IFNG, IL17A

Biological processes related to Chronic Inflammatory Demyelinating Polyradiculoneuropathy according to GeneCards Suite gene sharing:

(show all 14)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of interleukin-23 productionGO:003274710.3IFNG, IL17A
2cell deathGO:000821910.2IL17A, PMP22
3positive regulation of peptidyl-serine phosphorylation of STAT proteinGO:003314110.2IFNB1, IFNG
4positive regulation of osteoclast differentiationGO:004567210.0IFNG, IL17A
5regulation of interferon-gamma-mediated signaling pathwayGO:00603349.8IFNG, STAT1
6regulation of type I interferon-mediated signaling pathwayGO:00603389.7IFNB1, STAT1
7positive regulation of cell adhesionGO:00457859.7CXCL12, IFNG
8cellular response to interferon-betaGO:00354589.7IFNB1, STAT1
9blood circulationGO:00080159.4CXCL12, STAT1
10response to exogenous dsRNAGO:00433309.3IFNB1, STAT1
11defense response to virusGO:00516078.8IFNB1, IFNG, STAT1
12cytokine-mediated signaling pathwayGO:00192218.8IFNB1, IFNG, STAT1
13immune responseGO:00069558.7CXCL12, IFNG, IL17A, MBP
14response to virusGO:00096158.7CXCL12, IFNB1, IFNG

Molecular functions related to Chronic Inflammatory Demyelinating Polyradiculoneuropathy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cytokine receptor bindingGO:00051269.9IFNB1, IL17A
2cytokine activityGO:00051259.1IFNB1, IFNG, IL17A

Sources for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet